Current and emerging pharmacotherapy for prediabetes: are we moving forward?

3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial

(2017) Carel W le Roux et al.   LANCET

Update and Next Steps for Real-World Translation of Interventions for Type 2 Diabetes Prevention: Reflections From a Diabetes Care Editors’ Expert Forum

(2016) William T. Cefalu et al.   DIABETES CARE

Modifiable risk factors associated with prediabetes in men and women: a cross-sectional analysis of the cohort study in primary health care on the evolution of patients with prediabetes (PREDAPS-Study)

(2015) Alicia Díaz-Redondo et al.   BMC Family Practice

Sitagliptin improves glycaemic excursion after a meal or after an oral glucose load in Japanese subjects with impaired glucose tolerance

(2015) K. Kaku et al.   DIABETES OBESITY & METABOLISM

Prevalence of and Trends in Diabetes Among Adults in the United States, 1988-2012

(2015) Andy Menke et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management

(2015) Xavier Pi-Sunyer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Non-pharmacological interventions to reduce the risk of diabetes in people with impaired glucose regulation: a systematic review and economic evaluation.

(2014) M Gillett et al.   HEALTH TECHNOLOGY ASSESSMENT

The epidemic of pre-diabetes: the medicine and the politics

(2014) J. S. Yudkin et al.   BMJ-British Medical Journal

Benefits of Liraglutide Treatment in Overweight and Obese Older Individuals With Prediabetes

(2013) S. H. Kim et al.   DIABETES CARE

Sitagliptin improves beta-cell function in patients with acute coronary syndromes and newly diagnosed glucose abnormalities-the BEGAMI study

(2013) C. Hage et al.   JOURNAL OF INTERNAL MEDICINE

A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity-related risk factors (COR-II)

(2013) Caroline M. Apovian et al.   Obesity

Effects of Exenatide vs. Metformin on endothelial function in obese patients with pre-diabetes: a randomized trial

(2012) Aaron S Kelly et al.   Cardiovascular Diabetology

Pre-Diabetes, Metabolic Syndrome, and Cardiovascular Risk

(2012) Scott M. Grundy   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study

(2012) Leigh Perreault et al.   LANCET

Prediabetes: a high-risk state for diabetes development

(2012) Adam G Tabák et al.   LANCET

Bariatric Surgery and Prevention of Type 2 Diabetes in Swedish Obese Subjects

(2012) Lena M.S. Carlsson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy of Orlistat 60 mg on Weight Loss and Body Fat Mass in US Army Soldiers

(2012) Tracey J. Smith et al.   Journal of the Academy of Nutrition and Dietetics

Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide

(2011) A Astrup et al.   INTERNATIONAL JOURNAL OF OBESITY

Bariatric Surgery Significantly Decreases the Prevalence of Type 2 Diabetes Mellitus and Pre-Diabetes among Morbidly Obese Multiethnic Adults: Long-Term Results

(2011) Nestor de la Cruz-Muñoz et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS

Glucagon-like peptide-1 (GLP-1) receptor agonists: Differentiating the new medications

(2011) Jeffrey R. Unger et al.   Diabetes Therapy

Prevalence of Chronic Kidney Disease in US Adults with Undiagnosed Diabetes or Prediabetes

(2010) L. C. Plantinga et al.   Clinical Journal of the American Society of Nephrology

Prevalence, Diagnosis, and Treatment of Impaired Fasting Glucose and Impaired Glucose Tolerance in Nondiabetic U.S. Adults

(2010) A. Karve et al.   DIABETES CARE

Effects of Exenatide and Lifestyle Modification on Body Weight and Glucose Tolerance in Obese Subjects With and Without Pre-Diabetes

(2010) J. Rosenstock et al.   DIABETES CARE

Incidence rates and predictors of diabetes in those with prediabetes: the Strong Heart Study

(2010) Hong Wang et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Early weight loss and outcome at one year in obese adolescents treated with orlistat or placebo

(2010) Jean-Pierre Chanoine et al.   International Journal of Pediatric Obesity

Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled study

(2010) Bernard Zinman et al.   LANCET

Pathophysiology and aetiology of impaired fasting glycaemia and impaired glucose tolerance: does it matter for prevention and treatment of type 2 diabetes?

(2009) K. Færch et al.   DIABETOLOGIA

Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study

(2009) Arne Astrup et al.   LANCET

Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study

(2009) Adam G Tabák et al.   LANCET

10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study

(2009)   LANCET

Voglibose for prevention of type 2 diabetes mellitus: a randomised, double-blind trial in Japanese individuals with impaired glucose tolerance

(2009) Ryuzo Kawamori et al.   LANCET

The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study

(2008) Guangwei Li et al.   LANCET